Floatz logo

Human Chorionic Gonadotropin

Endocrine System Disorder

Merck KGaA, Darmstadt, Germanyprotein_peptidePhase 3Dormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Endocrine System Disorder cohort.

Asset / SponsorPhaseRating
TESTOSTERONE UNDECYLATE
Craig Hospital
Phase 4BB
FOLLITROPIN ALFA
Merck KGaA, Darmstadt, Germany
Phase 3BB
Msj-0011
Merck KGaA, Darmstadt, Germany
Phase 3BB
Irinotecan
Xiaoxiang Chen
Phase 2BB
Metformin
Assiut University
Phase 2B

View all 27 →

Same molecule, other indications

Human Chorionic Gonadotropin is also rated in:

polycystic ovary syndromeActive
BBB
Indicative · Phase 4
79 / 100
View asset →
infertility disorderDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
anovulationDormant
BB
Indicative · Phase 3
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →